Prelude Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-17,221
| Closed | -$447K | – | 1328 |
|
|
2020
Q4 | $447K | Buy |
+17,221
| New | +$447K | 0.01% | 394 |
|
|
2020
Q3 | – | Sell |
-7,558
| Closed | -$187K | – | 1746 |
|
|
2020
Q2 | $187K | Sell |
7,558
-834
| -10% | -$20.6K | 0.01% | 512 |
|
|
2020
Q1 | $116K | Buy |
+8,392
| New | +$116K | 0.01% | 333 |
|
|
2019
Q3 | – | Sell |
-2,198
| Closed | -$17K | – | 1500 |
|
|
2019
Q2 | $17K | Buy |
+2,198
| New | +$17K | ﹤0.01% | 949 |
|
|
2018
Q3 | – | Sell |
-300
| Closed | -$4K | – | 1623 |
|
|
2018
Q2 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 1281 |
|